

Exxua (Gepirone) is the first new-class antidepressant in years, but many patients can't find it. Learn why Exxua is so hard to find and what you can do.
You finally got the prescription you've been waiting for. Your doctor wrote you Exxua (Gepirone) — the first-in-class 5-HT1A receptor agonist antidepressant that's been making headlines for treating major depressive disorder without the sexual side effects or weight gain that plague so many other antidepressants. But when you called your pharmacy, you heard something frustrating: "We don't have it in stock."
If that sounds familiar, you're not alone. Thousands of patients across the country are running into the same problem in 2026. Let's break down exactly what's going on — and what you can do about it.
Exxua is the brand name for Gepirone, an extended-release antidepressant approved by the FDA in September 2023 for treating major depressive disorder (MDD) in adults. It belongs to the azapirone class of medications — the same family as Buspirone, which is commonly used for anxiety.
What makes Exxua different from most antidepressants is its mechanism of action. It works as a selective partial agonist of the serotonin 5-HT1A receptor, which means it targets serotonin in a more focused way than SSRIs or SNRIs. Importantly, clinical trials showed that Exxua does not carry warnings for sexual dysfunction or clinically significant weight gain — two side effects that cause many patients to stop their antidepressants.
Exxua comes in extended-release tablets (18.2 mg, 36.3 mg, 54.5 mg, and 72.6 mg) and is taken once daily with food. You can learn more about the medication in our comprehensive guide to Exxua.
There are several reasons why you may be having trouble finding Exxua at your local pharmacy in 2026.
Even though the FDA approved Exxua in September 2023, the drug wasn't commercially available to patients until January 20, 2026, when Aytu BioPharma launched it nationwide. That's a gap of more than two years between approval and availability. Many pharmacies are still in the process of adding Exxua to their inventory, which means stock can be spotty — especially at large retail chains.
Unlike most antidepressants that you can pick up at any CVS or Walgreens, Exxua is primarily distributed through the Aytu RxConnect pharmacy network — a network of over 1,000 participating pharmacies. This means major retail chains like CVS, Walgreens, and Rite Aid may not carry it at all, or may need to special-order it. This distribution model helps keep costs manageable for patients but limits where you can fill your prescription.
Exxua is the first oral selective 5-HT1A agonist approved for depression. For the millions of patients who've struggled with sexual side effects or weight gain from SSRIs and SNRIs, it represents a genuinely new option. That demand, combined with limited initial supply as Aytu scales up manufacturing and distribution, means pharmacies that do carry it may run out quickly.
As a brand-new, brand-name medication with no generic available, many insurance plans require prior authorization before covering Exxua. Some plans also require step therapy — meaning you must try and fail on cheaper generic antidepressants first. These requirements can delay when patients actually fill their prescriptions and create uncertainty for pharmacies about stocking levels.
The good news is that there are concrete steps you can take right now to locate Exxua.
The fastest way to find Exxua in stock near you is to use Medfinder. Our tool helps you search pharmacies in your area to see which ones have Exxua available, saving you the frustration of calling pharmacy after pharmacy.
Since Exxua is primarily distributed through the Aytu RxConnect network, ask your doctor or pharmacist which RxConnect pharmacies are near you. These pharmacies are the most likely to have Exxua in stock and may also offer reduced pricing through the program.
Independent pharmacies are often more flexible about ordering specialty medications than big chains. Call a few local independents and ask if they can order Exxua for you — many can have it within a few business days.
If your insurance requires prior authorization, make sure your doctor's office submits that paperwork as soon as possible. Aytu BioPharma offers a Prior Authorization Support Program that can help your provider navigate the process. The sooner the PA is approved, the sooner you can fill your prescription.
For more detailed tips, check out our guide on how to find Exxua in stock near you.
Without insurance, Exxua can cost approximately $1,500 to $1,800 per month for a 30-day supply, depending on the dosage strength. There is no generic version of Gepirone available yet — NCE exclusivity runs through September 2028.
The Aytu RxConnect program may reduce your out-of-pocket cost if you fill your prescription at a participating pharmacy. For more ways to save, see our post on how to save money on Exxua.
Finding Exxua in 2026 takes a bit more effort than filling a prescription for a well-established generic antidepressant. But the situation is improving as Aytu BioPharma expands distribution and more pharmacies add it to their inventory. In the meantime, tools like Medfinder can save you time and frustration.
If you're unable to find Exxua, don't stop your current treatment without talking to your doctor. There are alternative medications that may help while you wait for availability to improve.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.